Wageningen, The Netherlands
September 2, 2014
Today KeyGene announced that its Sequence Based Genotyping (SBG) patent portfolio has been further expanded with the recent grant of the patent entitled "Method for High Throughput AFLP-based Polymorphism Detection" in both the United States and China with patent numbers US 8,815,512 and ZL200680051561. The grant of these two broad patents is the most recent addition to KeyGene’s SBG patent portfolio in Europe, Japan and the United States now comprising a number of thirteen granted patents. In addition, proprietary expertise and software tools enable scientists of KeyGene and its licensees to generate, analyze and apply large amounts of sequence based marker data in a cost- and time effective manner. All in all it can be concluded that KeyGene has now established a unique and global SBG IPR position. The patents protect powerful methods that enable breeders to characterize their germplasm diversity, to identify genes of interest and to develop and apply genetic markers for the improvement of agronomic traits. This will ultimately result in improved crops that will feed the world in the future.
Keygene's SGB patent portfolio protects wordwide methods including RAD-Seq, double digest RAD-seq, 2b-RAD, GBS, tGBS, two-enzyme GBS, SLAF-seq and related methods which allow discovery and scoring of genetic markers without genome sequence information in a cost-effective way. This wave of new sequence basd genotyping technologies is replacing gel and array-based marker detection.
“Looking at the development of Sequence Based Genotyping IPR it can be concluded that KeyGene has developed an interesting global IPR position. I am confident that seed companies and AgBiotech companies from all around the world can benefit from SBG to improve their genetic material”, says Bart Klein, CEO of IP consultancy firm Primetime Biosciences.
“We are delighted by the grant of these very broad US and China patents, which further expands our proprietary SBG patent portfolio”, says Michiel van Eijk, CSO of KeyGene. “SBG is one of KeyGene's leading products in the rapidly developing next-generation sequencing space, seeing widespread adoption for research- and commercial purposes worldwide. KeyGene is committed and actively providing its clients and licensees access to SBG thereby supporting its strategic partners and customers to accelerate their business growth.”
Our patent portfolio is testament to KeyGene’s crop innovation power. KeyGene invites customers to benefit from its established position either via service and R&D projects at KeyGene or its licensees or by taking a license from KeyGene or buying our SBG kit linked with technology transfer.
Topics
Species
